logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research-Sioux City, Iowa

Verified
+17126396300
Source: Site record.
https://velocityclinicaltrials.com/locations/velocity-clinical-research-sioux-city

Basic Information

Site Overview

Source: Human-provided.

Velocity's research site in Sioux City frequently conducts clinical trials for a broad range of investigational treatments. The studies at this site explore vaccines and medicines developed to treat migraines, diabetes, acne, depression, high cholesterol, and other conditions. Acquired by Velocity in 2022, this location was founded in originally in Dakota Dunes in 2005 and later moved as part of Meridian Clinical Research.

Business Status

Source: Human-provided. OPEN

Business Category

Source: Human-provided. Medical clinic

Business Subcategory

Source: Human-provided. Medical clinic
Source: Trial-derived.
69Total Trials
Source: Trial-derived.
3Recruiting Trials
Source: Trial-derived.
16Active Trials
Source: Trial-derived.
47Completed Trials
Source: Trial-derived.
67Unique Conditions
Source: Trial-derived.
36Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. SARS-CoV-2 (7)Source: Trial-derived. Influenza, Human (4)Source: Trial-derived. Migraine (4)Source: Trial-derived. Obesity (4)Source: Trial-derived. Seasonal Influenza (4)Source: Trial-derived. COVID-19 (3)Source: Trial-derived. Influenza (3)Source: Trial-derived. Pneumococcal Disease (3)

Sponsors

Source: Trial-derived. ModernaTX, Inc. (17)Source: Trial-derived. Pfizer (13)Source: Trial-derived. Sanofi Pasteur, a Sanofi Company (5)Source: Trial-derived. Seqirus (5)Source: Trial-derived. Biomedical Advanced Research and Development Authority (4)Source: Trial-derived. Boehringer Ingelheim (3)Source: Trial-derived. Novavax (3)Source: Trial-derived. Bavarian Nordic (2)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. PCR / molecular
Source: AI-inferred. ELISA / immunoassay
Source: AI-inferred. Immunogenicity (anti-drug antibody) testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PBMC isolation & cryopreservation
Source: AI-inferred. Sequencing / genomics
Source: AI-inferred. Specimen packaging and shipment

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Cardiac monitoring
Source: AI-inferred. ELISpot assay
Source: AI-inferred. Electronic participant diary (eDiary/eCOA)
Source: AI-inferred. Electronic participant diary (eDiary/ePRO)
Source: AI-inferred. Electronic patient-reported outcome (eDiary) system
Source: AI-inferred. Hemagglutination inhibition (HAI) assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Microneutralization assay